KMB three-lens brief
Evidence-based stock research on KMB. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $114.86 — 17% above current (14 analysts). · Trading at 10% of its 52-week range — deep in the lower band.
- Trading at 10% of its 52-week range — deep in the lower band.
- Analyst mean target $114.86 — 17% above current (14 analysts).
- Debt-to-equity of 464.8 — balance-sheet-heavy.
KMB closed at $97.85 (-0.08%) as of 2026-04-25. Market cap: $32.48B. P/E (trailing) 20.1. Positives: analyst mean target $114.86 — 17% above current (14 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; debt-to-equity of 464.8 — balance-sheet-heavy.. Last quarter: Revenue $4.08B, net income $499.00M, free cash flow $912.88M.
Why three lenses on KMB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine KMBacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/KMB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath KMB brief"></iframe>